Systemic Dendrimer Delivery of Triptolide to Tumor-Associated Macrophages Improves Anti-Tumor Efficacy and Reduces Systemic Toxicity in Glioblastoma

Lignende værker

• Targeted systemic dendrimer delivery of CSF‐1R inhibitor to tumor‐associated macrophages improves outcomes in orthotopic glioblastoma
  af: Liaw, Kevin, et al.
  Udgivet: (2020)
• EXTH-40. SPECIFIC DENDRIMER-MEDIATED DELIVERY OF IMMUNOTHERAPY BLZ945 TO TUMOR-ASSOCIATED MACROPHAGES IMPROVES THERAPEUTIC EFFICACY IN GLIOBLASTOMA
  af: Liaw, Kevin, et al.
  Udgivet: (2019)
• Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer-Conjugated TSPO Ligand that Stimulates Antitumor Signaling in Glioblastoma
  af: Sharma, Anjali, et al.
  Udgivet: (2020)
• Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics
  af: Sharma, Anjali, et al.
  Udgivet: (2018)
• Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration
  af: Liaw, Kevin, et al.
  Udgivet: (2020)